Status:
UNKNOWN
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
Lead Sponsor:
Dermatologic Cooperative Oncology Group
Conditions:
Metastatic Melanoma
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The purpose of this multicenter study is to examine whether the proposed randomized treatment regime results in a significantly longer survival time and higher quality of life than any additionally ap...
Eligibility Criteria
Inclusion
- histological diagnosis of metastatic melanoma (stage IV)
- progressive disease after first-line chemotherapy or immuno-chemotherapy
- Karnofsky-index \> 60%
- informed consent
Exclusion
- Uvea melanoma
- another primary malignancy except basal cell carcinoma or cervical carcinoma in situ
- severe and/or uncontrolled medical disease (diabetes mellitus, cardiac insufficiency)
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00226473
Start Date
September 1 2001
End Date
September 1 2005
Last Update
June 21 2006
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Skin Cancer Unit, German Cancer Ressearch Center and Dept. of Dermatology, University Hospital of Mannheim
Mannheim, Baden-Wurttemberg, Germany, D-68167
2
Dept. of Dermatology, University Hospital Tuebingen
Tübingen, Baden-Wurttemberg, Germany, D-72076
3
Dept. of Dermatology, University of Frankfurt
Frankfurt am Main, Hesse, Germany, D-60590
4
Dept. of Dermatology, Medical Center Buxtehude
Buxtehude, Lower Saxony, Germany, D-21641